Investors buy Warner Chilcott in $3 billion acquisition deal

Share this article:
An investor group led by JPMorgan Chase and Credit Suisse
First Boston has acquired drug maker Warner Chilcott in a $3 billion
deal.
The drug company maintains joint headquarters in Northern Ireland
and Rockaway, N.J., with most of its 1,000 employees in the U.S.
Warner Chilcott is the maker of several products in the oral contraceptives, hormone replacement therapy, urology and dermatology markets.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions